Objective: To evaluate prospective associations between elevations in body mass index (BMI) at average age 27 and generalized anxiety disorder (GAD) and major depressive disorder (MDD) at average age 59 in a community sample of women. Design: Three waves of data collected over three decades were drawn from mothers in the Children in the Community (CIC) Study. Binary logistic regression was used to estimate predictive effects of two BMI cutpoints (X30 and X25) on GAD and MDD independent of other risks for psychopathology. Measurements: Information about height and weight was obtained by self-report in face-to-face interviews. GAD and MDD were assessed by structured interview covering DSM-IV diagnostic criteria. Other potential risk factors examined included age, race, education, prior depressive symptoms and marital status, chronic disease, social support and financial strain concurrent with GAD and MDD. Results: A baseline BMI X30 significantly increased the odds for subsequent GAD and MDD by 6.27 and 5.25 times, respectively, after adjusting for other significant risk factors. Odds of GAD also increased significantly given a baseline BMI X25 (by 2.44 times); however this association was not independent of other significant risk factors. Predictive associations between a baseline BMI X30 and MDD were not attenuated by attained BMI assessed at outcome. Conclusion: Findings extend existing evidence of the mental health consequences of obesity in a representative sample of mothers, and suggest that obesity may have long-term implications for mental distress in women at a clinical level over the adult years.
Introduction
Evidence to the contrary notwithstanding, [1] [2] [3] [4] [5] an increasing number of reports based on population samples in the United States (US) and elsewhere suggests that, among women, obesity raises the risk of psychopathology at both the sub-clinical [6] [7] [8] [9] [10] and clinical [11] [12] [13] levels. Because it is commonly assumed that obesity engenders mental distress, conclusions drawn from such cross-sectional findings typically attribute higher depression/anxiety symptom levels or disorder rates to elevated relative body weight (weight adjusted for height or body mass index (BMI)). Nonetheless, few studies actually have employed prospective data to test that hypothesis. The current research extends study findings that focus on comorbid associations between obesity and psychopathologic features in women, particularly at the clinical level, by investigating whether that link is longitudinal in nature. In the largest cross-sectional study, based on the 1992 National Longitudinal Alcohol Epidemiologic Survey, odds of past year DSM-IV major depression increased significantly by 37% among obese women (BMI X30) compared to women with a BMI between 20.77 and 29.99, and by 22% with each 10-unit rise in continuous BMI, after controlling for age, race, education, income and disease history.
11 National Comorbidity Survey Replication data were used to compare obese (BMIX30) and nonobese (BMIo30) women on lifetime prevalence of DSM-IV anxiety disorders (generalized anxiety disorder, panic disorder or agoraphobia) and mood disorders (major depression or bipolar disorder): odds increased significantly in obese women by 34 and 29%, respectively, and were not explained by confounding due to age, smoking or comorbid psychiatric disorder. 12 In findings from the Third National Health and Nutrition Examination Survey, unadjusted odds of past month DSM-III major depression increased significantly by 82% in obese women (BMI X30) and by 3.78 times in severely obese women (BMI X40) compared to women with a BMI between 18.5 and 24.99; tabulated adjusted odds, however, were not gender-specific. 13 It is only recently that findings attributing increased risk of depression to elevations in BMI among women have been based on long-term prospective data, much of it being drawn from adolescent samples. Girls aged 14 in the Northern Finland 1966 Birth Cohort Study with a BMI X23.81, the gender-and age-specific 95th percentile, were at significantly greater odds (by 64%) of having elevated scores on the Hopkins Symptom Checklist (HSCL)-25-Depression Scale 17 years later after adjustment for parental marital status and social class, and disease, tobacco use, diet, physical activity and marital status at outcome. 14 We recently evaluated those associations among offspring of the women studied here: girls in the Children in the Community (CIC) Study who were overweight between their 12th and 18th birthdays were at nearly four times the risk of DSM-IV major depression and at three times the risk of a DSM-IV anxiety disorder an average of 16 years later after adjustment for age, race, family socioeconomic status and tobacco use. 15 On the other hand, in the Great Smoky Mountain Study, chronically obese girls assessed over an 8-year period were at increased risk of oppositional defiant disorder but not anxiety or depressive disorder; however, outcomes were assessed in adolescence. 16 Evidence that obesity may be implicated in the etiology of clinical depression in women is based on prospective data drawn from adults over age 50 in the Alameda County Study: 17 baseline obesity (BMI X30) significantly increased the odds of incident DSM-IV major depression by 79% 5 years later after adjustment for potential confounders that included measures of status attributes, personal and social resources and stressors. Because that association did not differ significantly across gender, however, separate odds were not given for men and women. Additional support for a causal pathway from obesity to psychiatric disturbance, most notably depression, comes from research on change in psychopathologic features among obese individuals as a function of weight loss after behavioral, dietary 18, 19 or surgical 20, 21 intervention. For example, Dixon et al. 20 reported a significant and sustained drop in scores on the Beck Depression Inventory from 17.779.5 at baseline to 7.876.5 and 9.677.7 1 and 4 years later, respectively, following gastric-restrictive weight loss surgery. Nonetheless, obese individuals who enter weight reduction programs are reported to be more depressed or more anxious than obese individuals in the general population, and thus may be more likely to experience a decline in symptoms with weight loss. 22 Prevalence of overweight and obesity in the US population now exceeds 60% 23 and is expected to continue to rise; 24 in addition, the rapid escalation in obesity rates has been implicated in a concomitant increase in incident depression. 25, 26 Despite that overlap, in contrast to substantial documentation of the adverse impact of rising BMI levels on medical conditions and longevity, [27] [28] [29] [30] [31] prospective evidence pertaining to the impact of BMI on mental health status has been much less prominent in the literature. Consequently, recognition of obesity as a risk factor for psychopathology, particularly at the clinical level, remains tentative. Longitudinal research on this issue is useful in that it will expand our knowledge of antecedent factors that may contribute to increased risk of affective disorder, especially among adult women, who are more prone to obesity 21 and to anxiety and depression. 32 Moreover, studies of mental health consequences will broaden our understanding of the detrimental influence of obesity on overall well-being and at the same time inform more accurate estimates of the social, medical and public health costs often associated with this condition. Accordingly, given the dearth of empirical work on this issue, we examine prospective associations between obesity and psychopathologic features assessed at a clinical level, namely DSM-IV generalized anxiety disorder (GAD) and major depressive disorder (MDD), in a community-based sample of women. Obesity is defined here as a BMI X30, the recommended cutpoint for obesity in adults based on the National Heart, Blood, and Lung Institute (NHBLI) 33 guidelines. Evidence of a prospective association between elevated relative body weight and anxiety disorder is especially limited; consequently, what BMI cutpoint is most useful to determine a potential link remains unclear. Thus, we also examine the predictive utility of a BMI X25, the recommended NHBLI cutpoint that includes both overweight and obesity.
Longitudinal data were drawn from mothers in the CIC Study, an ongoing investigation of child development and behavior in a randomly selected sample of families, to analyze the predictive effects of a BMI X30 and X25 (at average age 27) on increased risk of GAD and MDD (at average age 59). The other covariates considered here, including age, education level, prior depressive symptoms, marital status, chronic medical disease, social support and financial strain, are widely held to be determinants of elevated risk for depressive disorder and other mental distress in women. [34] [35] [36] [37] Moreover, others have employed measures of similar constructs to adjust associations between obesity and psychopathologic features for those putative risk factors. 17, 38, 39 Race also has been implicated in differential rates of depression among women; 40 thus, it too is examined. In addition, we investigate whether prospective associations between BMI and GAD or MDD are mediated by attained BMI more proximal to psychopathology.
Hypotheses
The literature upon which hypotheses of long-term prospective associations of obesity and psychopathology may be (29) , illness (25) and failure to locate (21) , or time constraints of the study (18) No other significant differences between those two groups were noted in study variables obtained in the first two waves.
Procedure Face-to-face interviews were conducted in the women's homes by trained interviewers with a minimum of 15 years experience. Written informed consent was obtained in adherence to institutional guidelines and after interview procedures has been fully explained.
Measures Body mass index. In 1975, the women were asked how much they weighed just prior to pregnancy with the study child, about 5 years earlier on average, when they were average age 27 (s. Other potential risk factors for psychopathology. Among the covariates examined was age at outcome, race (set at 0 ¼ Caucasian, 1 ¼ other) and education level (set at 0 ¼ X12th grade education, 1 ¼ o12th grade education). Prior depressive symptoms were measured with a nine-item 44, 45 Moreover, it is strongly associated with subsequent GAD and MDD in the current study sample (as shown in Tables 3 and 4 , respectively); thus, it is used to adjust for prior psychopathology in the analyses. Other covariates were assessed concurrently with GAD and MDD at average age 59. Marital status was dichotomized (set at 0 ¼ married, 1 ¼ unmarried (divorced, separated or widowed)). Information about chronic medical conditions (categorized as autoimmune, cancer, cardiovascular, diabetes, gastrointestinal, musculoskeletal, neurological or respiratory disease) that interfered with role function or for which medication was taken in the past 12 months was obtained by interview and dichotomized (set at 0 ¼ absent, 1 ¼ present). Presence of a chronic medical condition has been related to self-reported health and depressive syndrome in CIC Study mothers. 46 Psychopathology at outcome. Women responded to 10 and 16 interview items covering DSM-IV diagnostic criteria for GAD and MDD, respectively, at average age 59. Criteria for GAD were excessive anxiety and worry most days in the past 6 months that could not be explained by specific fears or medication or substance use or confined to features of another Axis I disorder, and an inability to control the anxiety/worry. Also required was a minimum of three of six symptoms (for example, symptoms of tension such as a pounding heart, clammy hands, an upset stomach, trouble sleeping, or muscle tension; feeling irritable, keyed up or on edge; difficulty concentrating) and impaired functioning in occupational, social, or interpersonal domains. Criteria for MDD were depressed mood, or being hopeless or suicidal, or loss of interest/lack of enjoyment in all things most of the day nearly every day for at least 2 weeks in the past year that could not be explained by medication, substance use or stressful events. Also required was a minimum of five of nine symptoms that included depressed mood (for example, tiring easily, feeling fatigued or having less energy than usual; feeling guilty or to blame for things that happened; feeling worthless and without value; continuing thoughts about death or suicide); and impaired functioning in occupational, social or interpersonal domains during the depressed state.
Prospective associations between this measure of MDD and social support and neuroticism in an overlapping sample of CIC mothers support its validity. 47 Statistical analysis Differences in proportions were tested with w 2 tests, and differences in means by two-sample t-tests. Binary logistic regression was used to estimate associations between meeting DSM-IV criteria for GAD and MDD at average age 59 and a baseline BMI X30 and X25 (that is, at average age 27), controlling for other potential risk factors that included age, race, education level, prior depressive symptoms (that is, at average age 38) and marital status, chronic disease, low social support, financial strain and attained BMI assessed at outcome (that is, at average age 59). Regression analyses were conducted with the SPSS (15.0) for Windows software (binary logistic regression module) (SPSS Inc.). 48 Generalized anxiety disorder and MDD each were examined in a separate set of parallel models. First, bivariate associations between each covariate and the disorders were examined to determine crude or unadjusted odds of GAD and MDD (model 1). If a bivariate association was not significant, that covariate was not considered in any subsequent model for the disorder; subsequent models were contingent upon a significant bivariate association between baseline BMI and disorder. With the exception of attained BMI, all significant covariates were examined simultaneously with baseline BMI X30 (model 2) and X25 (model 3), thus yielding adjusted odds for GAD and MDD. Finally, to determine whether more proximal elevations in BMI would mediate predictive associations between baseline BMI and GAD or MDD, attained BMI was added to models 2 and 3 where effects of baseline BMI remained significant. Attained BMI values X30, X25 and continuous were examined.
Scales assessing prior depressive symptoms and attained continuous BMI were standardized in the regression analyses to facilitate interpretation. Alpha was set at 0.05 for all analyses.
Results
Sample frequencies (%) or means (s.d.) and ranges for all study variables are shown in Table 1 ; continuous BMI at baseline, albeit not considered in the main analyses, is included to examine normative change in relative body weight. The correlation matrix in Table 2 shows the degree of association between all study covariates employed in the Bivariate associations between covariates and GAD and MDD At average age 59, 27 (5.0%) and 42 (7.7%), women were diagnosed with GAD or MDD, respectively (Table 1) . Associations between covariates and disorder are shown in Table 3 (for GAD) and Table 4 (for MDD). At the bivariate level, odds of both GAD and MDD rose significantly among women with a BMI X30 at baseline and those who were younger, had less than a 12th grade education, or had prior elevated depressive symptoms, and in women who were unmarried, had a chronic disease, or experienced low social support or financial strain at average age 59. Unadjusted odds of GAD but not MDD also rose significantly among women with a BMI X25; thus, a BMI X25 was not considered in any subsequent MDD model. Because there was no significant (Table 3) . Adjusted odds of GAD also remained significantly elevated among younger women, women with elevated prior depressive symptoms and women with a chronic disease in both model 2 (BMI X30) and model 3 (BMI X25). The Hosmer-Lemeshow test, 49 which determines whether predicted probabilities for covariates match observed probabilities in binary logistic regression models, was used to assess goodness-of-fit; the large P-values obtained here indicate a good match in GAD model 2 (w ¼ 5.22, P ¼ 0.78) and in GAD model 3 (w ¼ 4.56, P ¼ 0.80). To determine whether attained BMI mediated the association between a baseline BMI X30 and GAD, bivariate relations between attained BMI and GAD were examined first. As shown in Table 5 , no attained BMI value among X30, X25 or continuous was significantly related to GAD; thus, mediational effects could not be tested.
Major depressive disorder
Odds of MDD rose significantly with a baseline BMI X30 (OR ¼ 5.25, 95% CI ¼ 1.41-19.58) independent of other risk factors, including age, education, prior depressive symptoms, marital status, chronic disease, low social support and financial strain (Table 4) . Odds of MDD also remained significantly elevated among younger women, women with less than a 12th grade education, women with elevated prior depressive symptoms and women under concurrent financial strain. As with the GAD models, the large P-value obtained here with the Hosmer-Lemeshow test 49 supports To determine whether attained BMI mediated the association between a baseline BMI X30 and MDD, bivariate relations between attained BMI and MDD were examined first: As shown in Table 5 , only attained continuous BMI significantly increased the odds of MDD, with the likelihood of meeting diagnostic criteria increasing by 47% with each standard deviation increase in attained continuous BMI (that is, an increase equivalent to 6.3 BMI units). With the addition of attained continuous BMI in adjusted model 2 shown in Table 4 , odds of MDD remained significant for a baseline BMI X30 (OR ¼ 3.95, 95% CI ¼ 1.04-15.52), whereas the bivariate association between attained continuous BMI and MDD was no longer significant after adjusting for other risk factors, whether or not a baseline BMI X30 was included among the covariates (data not tabulated).
Discussion
The primary purpose of this study was to investigate prospective associations between obesity and psychopathologic features assessed at the clinical level in a representative sample of women. The key finding of a long-term impact of obesity on both GAD and MDD independent of other more substantiated risk factors implicated in psychopathology is consistent with our main hypothesis and expands the available database on the temporal link between obesity and mental health consequences in women. In particular, the predictive effect of obesity on MDD is compatible with reports of an increased risk of incident major depression and other indicators of mental distress over a 5-year interval in obese adults aged 50 and older, 17, 39 and provides added support for obesity as a risk factor for subsequent major depression among adult women. Moreover, our findings also are among the first to establish a temporal connection between obesity and anxiety disorder, and as such have heuristic value with respect to furthering research in this area.
Perhaps what was most striking about these findings was the three-decade period over which obesity predicted psychopathology in this sample, a considerably lengthier interval than has been examined previously. Obesity appears to be a persistent condition that often precedes depression among women, 22, 50 and has been associated with increased exposure to stressful life experiences in adulthood, including poor interpersonal and occupational outcomes and reduced economic circumstances. 51 Obese women report lowered quality of life 6 and less engagement in and enjoyment of pleasurable experiences and activities, 52 and often are the targets of recurrent public ridicule and discrimination. 53 The most common and frequently reported source of interpersonal stigma is close family members; 54 thus, wives and mothers may experience more daily hassles over excess weight than unmarried or childless women. Moreover, unlike other stigmatized groups, obese women appear to internalize the negative perceptions toward obesity held by society and to devaluate themselves. 55 It may be that, at least for some obese women, increasing cumulative stress burden and poor self-concept eventually lower the threshold at which stress exposure may precipitate depression. The significant predictive effect of the less severe cutpoint of a BMI X25 on GAD was attenuated after adjusting for other putative risk factors; moreover, the heightened odds of MDD given a baseline BMI X25 were not significant even prior to adjustment. This finding is compatible with reports that associations between less severe levels of elevated relative body weight and psychopathologic features are either weaker 13 or no longer hold once adjusted for other relevant risks. 38 It also suggests that, for women, a more severely elevated BMI may precipitate adverse life experiences that are significantly greater in number or severity. Examination of change in BMI across the three decades indicated that the proportion of women with a BMI X30 rose from 3.1 to 31.8%, thus increasing by about 10 times; corresponding proportions for women with a BMI X25 were 15.4 and 63.1%, quadrupling the rate of those either overweight or obese. The rise in relative body weight with age found here is compatible with cross-sectional reports of spiraling overweight and obesity rates. 23 We also found that, albeit odds of comorbid MDD increased with elevations in attained continuous BMI at average age 59, the association was not independent of other significant covariates. This finding is compatible with reports based on both cross-sectional 12 and short-term prospective 38 data, suggesting that increased risk of depression may be limited to more extreme elevations in relative body weight. Nonetheless, at average age 59, neither a BMI X30, a criterion met by 173 (31.9%) women, nor a BMI X25, a criterion met by 343 (63.1%) women, significantly increased the odds of comorbid MDD at the bivariate level (Table 5) . Thus, elevations in continuous BMI (but not a BMI X30 or X25) at average age 59 significantly increased the odds of comorbid MDD, at least prior to adjusting for other risk factors, whereas a baseline BMI X30 significantly increased both unadjusted and adjusted odds of MDD three decades later. Such findings bolster the argument that risk factors implicated in the etiology of psychopathologic features may differ from those that exacerbate or prolong them. 56 Given the more than three-decade interval between assessment of baseline BMI and attained BMI in this sample, they also indicate that age may be a factor in the relation between obesity and psychological distress in women. These findings should be interpreted with the following cautions in mind. Self-reported BMI is measured with some bias; however, several validation studies suggest that this bias is unlikely to affect conclusions about relations between BMI and psychopathology, particularly in longitudinal studies. [57] [58] [59] Although this study is prospective with respect to the association of BMI with psychopathology, the use of Obesity and psychopathology S Kasen et al pre-pregnancy weight to calculate baseline BMI also may have contributed to misclassification in the direction of underestimation owing to memory-related bias. Nonetheless, research on the validity of long-term recall of body weight supports the relative accuracy and usefulness of such data as a proxy for measured weight in epidemiologic studies, and corroborates its predictive utility. [59] [60] [61] [62] For example, Casey et al. 60 found that, among 50-year-old participants, the accuracy of recalled height and weight measured in childhood, adolescence and at ages 30 and 40 did not differ significantly from the accuracy of current self-reported height and weight that also was measured at the same time. Similarly, Norgan and Cameron 62 reported that recall of previous height and weight over a 27-to 37-year interval (measured at 18 to 24 years old) was not significantly influenced by the passage of time. Study data were based on a primarily Caucasian sample of mothers; consequently, confirmation requires replication in more diverse samples of women with other racial backgrounds and women without offspring. Analyses were based on a onetime assessment of mental disorders; thus, the impact of BMI on incident disorder could not be ascertained. We were, however, able to adjust for prior depressive symptoms which were highly related to both GAD and MDD and remained independent of all other covariates in the adjusted models. Moreover, elevations in BMI and disorder rates may wax and wane over the lengthy interval examined here as a consequence of changing risk and protective factors; thus, data based on more than two assessment points are needed to capture potential change and reciprocity of effects. Another limitation was the small cell sizes owing to small proportions of women in the obese category at baseline and who met diagnostic criteria for GAD or MDD at outcome, which limited statistical power and precluded investigating whether associations between obesity and psychopathology were conditional on other risk factors. Nonetheless, the current study is based on long-term prospective data obtained from a representative sample of women. The study design also incorporates two BMI cutpoints of differing severity, DSM-IV diagnostic criteria for GAD and MDD, controls for established risk factors of those disorders, and considers the impact of baseline and attained BMI simultaneously. In addition, these findings are among the first to support and extend existing findings based on prospective data regarding the causal direction of the link between obesity and depressive and anxiety disorders among women, and as such have critical clinical and public health implications related to the individual and societal costs of obesity to the mental health status of women.
